| Literature DB >> 3466694 |
R Lionetto, P Pronzato, P F Conte, M R Sertoli, D Amoroso, R Rosso.
Abstract
Twenty-nine patients with metastatic breast cancer were treated orally with idarubicin (15 mg/m2 X 3 days every 3-4 weeks). Objective response was seen in 31% of all patients. Toxicity was acceptable. There should be further clinical trials of new anthracycline antibiotic.Entities:
Mesh：
Substances：
Year: 1986 PMID： 3466694
Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960